Stephen Yoder Net Worth & Insider Trades

Stephen Yoder - Chief Executive Officer, Pieris Pharmaceuticals, Inc

As of February 24, 2022

What is Stephen Yoder's Net Worth?

The current estimated net worth of Pieris Pharmaceuticals, Inc's Chief Executive Officer, Stephen Yoder, is estimated to be about $108.6K . Stephen Yoder owns about 6,000 units of Pieris Pharmaceuticals, Inc common stock. In the last 6 years at Pieris Pharmaceuticals, Inc, Stephen Yoder has sold an estimated value of $0 worth.

What is Stephen Yoder's Past Insider Trading?

Stephen Yoder's largest purchase order was 6,000 units , worth over $10.08K on June 15, 2016. In total, Stephen Yoder has made about 8 transactions over 6 years of their time at Pieris Pharmaceuticals, Inc. Stephen Yoder usually trades in February, with the busiest year in 2016.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Stephen Yoder's Salary in 2020?

As Chief Executive Officer of Pieris Pharmaceuticals, Inc, Stephen Yoder has a total base salary of $535,000 . Stephen Yoder received compensation valued at about $1,538,829 in 2020 after becoming Chief Executive Officer. The vast majority of their compensation came in the form of option awards of $808,699 , other earnings, plans or compensations of $173,875 , and other compensation of $21,255 .

What is Stephen Yoder's' Mailing Address?

  • Mailing address is Lise-Meitner-Strasse 30 C/o Pieris Pharmaceuticals, Inc. Freising-Weihenstephan 2M 85354 Germany

Pieris Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Stephen S. Yoder 2020 $535,000 $808,699 $173,875 $21,255 $1,538,829
Stephen S. Yoder 2019 $515,000 $815,670 $208,575 $54,353 $1,593,598
Hitto Kaufmann, Ph.D.* 2020 $330,583 $86,646 $107,143 $20,958 $545,330
Hitto Kaufmann, Ph.D.* 2019 $108,176 $956,299 $36,804 - $1,101,279
Thomas Bures 2020 $283,250 $154,038 $65,856 $11,400 $514,544
Thomas Bures 2019 $257,500 $152,938 $66,242 - $476,680
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1583648/000158364821000015/pirs2021proxystatement.htm

What are Pieris Pharmaceuticals, Inc's Past Insider Trades?

Pieris Pharmaceuticals, Inc's most recent insider trade came on May 16, 2022 by Tim Demuth who bought 6,000 units worth $10.26K . In the last 7 years, insiders at Pieris Pharmaceuticals, Inc have sold an estimated value of $25.85M and bought an estimated value of $3.65M worth of shares. Insider trading is most common in January, with the busiest year in 2017. The most active traders at the company are Michael Richman, Director,  Quang Chau Khuong,  and Christopher Kiritsy, Director .

PIERIS PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1